位置:首页 > 蛋白库 > ACEA_YEAST
ACEA_YEAST
ID   ACEA_YEAST              Reviewed;         557 AA.
AC   P28240; D3DLX0;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   03-AUG-2022, entry version 179.
DE   RecName: Full=Isocitrate lyase {ECO:0000303|PubMed:1551398};
DE            Short=ICL {ECO:0000305};
DE            EC=4.1.3.1 {ECO:0000269|PubMed:1551398, ECO:0000269|PubMed:23159490, ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
DE   AltName: Full=Methylisocitrate lyase {ECO:0000303|PubMed:4259654};
DE            Short=MICA {ECO:0000305};
DE            EC=4.1.3.30 {ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
DE   AltName: Full=Threo-D(S)-isocitrate glyoxylate-lyase {ECO:0000305};
GN   Name=ICL1 {ECO:0000303|PubMed:1551398};
GN   OrderedLocusNames=YER065C {ECO:0000312|SGD:S000000867};
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=1551398; DOI=10.1111/j.1432-1033.1992.tb16720.x;
RA   Fernandez E., Moreno F., Rodicio R.;
RT   "The ICL1 gene from Saccharomyces cerevisiae.";
RL   Eur. J. Biochem. 204:983-990(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND INDUCTION.
RC   STRAIN=DBY939;
RX   PubMed=8319292; DOI=10.1007/bf00312621;
RA   Schoeler A., Schueller H.-J.;
RT   "Structure and regulation of the isocitrate lyase gene ICL1 from the yeast
RT   Saccharomyces cerevisiae.";
RL   Curr. Genet. 23:375-381(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169868;
RA   Dietrich F.S., Mulligan J.T., Hennessy K.M., Yelton M.A., Allen E.,
RA   Araujo R., Aviles E., Berno A., Brennan T., Carpenter J., Chen E.,
RA   Cherry J.M., Chung E., Duncan M., Guzman E., Hartzell G., Hunicke-Smith S.,
RA   Hyman R.W., Kayser A., Komp C., Lashkari D., Lew H., Lin D., Mosedale D.,
RA   Nakahara K., Namath A., Norgren R., Oefner P., Oh C., Petel F.X.,
RA   Roberts D., Sehl P., Schramm S., Shogren T., Smith V., Taylor P., Wei Y.,
RA   Botstein D., Davis R.W.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome V.";
RL   Nature 387:78-81(1997).
RN   [4]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=4259654; DOI=10.1016/0003-9861(72)90118-x;
RA   McFadden B.A., Rose I.A., Williams J.O.;
RT   "Production of pyruvate and succinate by action of isocitrate lyase on
RT   alpha-methylisocitrate.";
RL   Arch. Biochem. Biophys. 148:84-88(1972).
RN   [6]
RP   PHOSPHORYLATION, ACTIVITY REGULATION, AND INDUCTION.
RX   PubMed=3076186; DOI=10.1099/00221287-134-9-2499;
RA   Lopez-Boado Y.S., Herrero P., Fernandez M.-T., Fernandez R., Moreno F.;
RT   "Glucose-stimulated phosphorylation of yeast isocitrate lyase in vivo.";
RL   J. Gen. Microbiol. 134:2499-2505(1988).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=3059712; DOI=10.1002/yea.320040105;
RA   Lopez-Boado Y.S., Herrero P., Fernandez M.-T., Fernandez R., Moreno F.;
RT   "Purification of isocitrate lyase from Saccharomyces cerevisiae.";
RL   Yeast 4:41-46(1988).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=8870676; DOI=10.1042/bj3190255;
RA   Taylor K.M., Kaplan C.P., Gao X., Baker A.;
RT   "Localization and targeting of isocitrate lyases in Saccharomyces
RT   cerevisiae.";
RL   Biochem. J. 319:255-262(1996).
RN   [9]
RP   MUTAGENESIS OF THR-53.
RX   PubMed=8641464; DOI=10.1016/0014-5793(96)00344-4;
RA   Ordiz I., Herrero P., Rodicio R., Moreno F.;
RT   "Glucose-induced inactivation of isocitrate lyase in Saccharomyces
RT   cerevisiae is mediated by the cAMP-dependent protein kinase catalytic
RT   subunits Tpk1 and Tpk2.";
RL   FEBS Lett. 385:43-46(1996).
RN   [10]
RP   MUTAGENESIS OF LYS-216 AND MET-220.
RX   PubMed=8923733;
RX   DOI=10.1002/(sici)1097-0061(199610)12:13<1285::aid-yea5>3.0.co;2-b;
RA   Heinisch J.J., Valdes E., Alvarez J., Rodicio R.;
RT   "Molecular genetics of ICL2, encoding a non-functional isocitrate lyase in
RT   Saccharomyces cerevisiae.";
RL   Yeast 12:1285-1295(1996).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=9370278; DOI=10.1016/s0378-1119(97)00311-9;
RA   Chaves R.S., Herrero P., Ordiz I., Angeles del Brio M., Moreno F.;
RT   "Isocitrate lyase localisation in Saccharomyces cerevisiae cells.";
RL   Gene 198:165-169(1997).
RN   [12]
RP   INDUCTION.
RX   PubMed=9425123; DOI=10.1042/bj3290383;
RA   Ordiz I., Herrero P., Rodicio R., Gancedo J.M., Moreno F.;
RT   "A 27 kDa protein binds to a positive and a negative regulatory sequence in
RT   the promoter of the ICL1 gene from Saccharomyces cerevisiae.";
RL   Biochem. J. 329:383-388(1998).
RN   [13]
RP   INDUCTION.
RX   PubMed=10540293; DOI=10.1046/j.1365-2958.1999.01588.x;
RA   Rahner A., Hiesinger M., Schueller H.-J.;
RT   "Deregulation of gluconeogenic structural genes by variants of the
RT   transcriptional activator Cat8p of the yeast Saccharomyces cerevisiae.";
RL   Mol. Microbiol. 34:146-156(1999).
RN   [14]
RP   DISRUPTION PHENOTYPE, AND FUNCTION.
RX   PubMed=11452311; DOI=10.1038/35083594;
RA   Lorenz M.C., Fink G.R.;
RT   "The glyoxylate cycle is required for fungal virulence.";
RL   Nature 412:83-86(2001).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=17651441; DOI=10.1111/j.1742-4658.2007.05959.x;
RA   Sarry J.E., Chen S., Collum R.P., Liang S., Peng M., Lang A., Naumann B.,
RA   Dzierszinski F., Yuan C.X., Hippler M., Rea P.A.;
RT   "Analysis of the vacuolar luminal proteome of Saccharomyces cerevisiae.";
RL   FEBS J. 274:4287-4305(2007).
RN   [16]
RP   INDUCTION.
RX   PubMed=17428308; DOI=10.1111/j.1567-1364.2007.00236.x;
RA   Belinchon M.M., Gancedo J.M.;
RT   "Glucose controls multiple processes in Saccharomyces cerevisiae through
RT   diverse combinations of signaling pathways.";
RL   FEMS Yeast Res. 7:808-818(2007).
RN   [17]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20457600; DOI=10.1074/jbc.m109.075143;
RA   Brown C.R., Hung G.C., Dunton D., Chiang H.L.;
RT   "The TOR complex 1 is distributed in endosomes and in retrograde vesicles
RT   that form from the vacuole membrane and plays an important role in the
RT   vacuole import and degradation pathway.";
RL   J. Biol. Chem. 285:23359-23370(2010).
RN   [18]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=21246628; DOI=10.1002/yea.1828;
RA   Lee Y.J., Jang J.W., Kim K.J., Maeng P.J.;
RT   "TCA cycle-independent acetate metabolism via the glyoxylate cycle in
RT   Saccharomyces cerevisiae.";
RL   Yeast 28:153-166(2011).
RN   [19]
RP   FUNCTION.
RX   PubMed=22876324; DOI=10.1371/journal.pone.0042475;
RA   Chen Y., Siewers V., Nielsen J.;
RT   "Profiling of cytosolic and peroxisomal acetyl-CoA metabolism in
RT   Saccharomyces cerevisiae.";
RL   PLoS ONE 7:E42475-E42475(2012).
RN   [20]
RP   CATALYTIC ACTIVITY, FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=23159490; DOI=10.1016/j.bbamcr.2012.11.008;
RA   Casatta N., Porro A., Orlandi I., Brambilla L., Vai M.;
RT   "Lack of Sir2 increases acetate consumption and decreases extracellular
RT   pro-aging factors.";
RL   Biochim. Biophys. Acta 1833:593-601(2013).
RN   [21]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=24062879; DOI=10.1155/2013/802870;
RA   Orlandi I., Ronzulli R., Casatta N., Vai M.;
RT   "Ethanol and acetate acting as carbon/energy sources negatively affect
RT   yeast chronological aging.";
RL   Oxid. Med. Cell. Longev. 2013:802870-802870(2013).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION.
RX   PubMed=24665361; DOI=10.3402/jev.v3.23497;
RA   Giardina B.J., Stein K., Chiang H.L.;
RT   "The endocytosis gene END3 is essential for the glucose-induced rapid
RT   decline of small vesicles in the extracellular fraction in Saccharomyces
RT   cerevisiae.";
RL   J. Extracell. Vesicles 3:0-0(2014).
RN   [23]
RP   SUBCELLULAR LOCATION.
RX   PubMed=24520859; DOI=10.1186/1477-5956-12-9;
RA   Giardina B.J., Stanley B.A., Chiang H.L.;
RT   "Glucose induces rapid changes in the secretome of Saccharomyces
RT   cerevisiae.";
RL   Proteome Sci. 12:9-9(2014).
CC   -!- FUNCTION: Catalyzes the formation of succinate and glyoxylate from
CC       isocitrate, a key step of the glyoxylate cycle, which operates as an
CC       anaplerotic route for replenishing the tricarboxylic acid cycle.
CC       Required for growth on ethanol or acetate, but dispensable when
CC       fermentable carbon sources are available. Acts also on 2-
CC       methylisocitrate. {ECO:0000269|PubMed:11452311,
CC       ECO:0000269|PubMed:1551398, ECO:0000269|PubMed:22876324,
CC       ECO:0000269|PubMed:23159490, ECO:0000269|PubMed:3059712,
CC       ECO:0000269|PubMed:4259654}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=D-threo-isocitrate = glyoxylate + succinate;
CC         Xref=Rhea:RHEA:13245, ChEBI:CHEBI:15562, ChEBI:CHEBI:30031,
CC         ChEBI:CHEBI:36655; EC=4.1.3.1; Evidence={ECO:0000269|PubMed:1551398,
CC         ECO:0000269|PubMed:23159490, ECO:0000269|PubMed:3059712,
CC         ECO:0000269|PubMed:4259654};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2S,3R)-3-hydroxybutane-1,2,3-tricarboxylate = pyruvate +
CC         succinate; Xref=Rhea:RHEA:16809, ChEBI:CHEBI:15361,
CC         ChEBI:CHEBI:30031, ChEBI:CHEBI:57429; EC=4.1.3.30;
CC         Evidence={ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:P9WKK7};
CC   -!- ACTIVITY REGULATION: Phosphorylated and inactivated after addition of
CC       glucose to the cell culture (repressing conditions).
CC       {ECO:0000269|PubMed:3076186}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.4 mM for threo-D(S)-isocitrate (at pH 7.0)
CC         {ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
CC         KM=0.6 mM for threo-D(S)-2-methylisocitrate (at pH 7.0 and 30 degrees
CC         Celsius) {ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
CC         Note=The Vmax with threo-D(S)-isocitrate as substrate is 5-fold
CC         higher than with threo-D(S)-2-methylisocitrate as substrate.
CC         {ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
CC       pH dependence:
CC         Optimum pH is 7. {ECO:0000269|PubMed:3059712,
CC         ECO:0000269|PubMed:4259654};
CC       Temperature dependence:
CC         Thermostable for 60 minutes up to 50 degrees Celsius.
CC         {ECO:0000269|PubMed:3059712, ECO:0000269|PubMed:4259654};
CC   -!- PATHWAY: Carbohydrate metabolism; glyoxylate cycle; (S)-malate from
CC       isocitrate: step 1/2. {ECO:0000305|PubMed:3059712,
CC       ECO:0000305|PubMed:4259654}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:3059712}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:20457600,
CC       ECO:0000269|PubMed:8870676, ECO:0000269|PubMed:9370278}. Secreted,
CC       extracellular space, extracellular matrix {ECO:0000269|PubMed:24520859,
CC       ECO:0000269|PubMed:24665361}. Vacuole {ECO:0000269|PubMed:17651441,
CC       ECO:0000269|PubMed:20457600}. Note=Localizes in extracellular vesicles
CC       during growth on lown glucose. When glucose is added to glucose-starved
CC       wild-type cells, levels of extracellular ICL1 get reduced. Targeted to
CC       the vacuole for degradation in 3-day-starved cells.
CC       {ECO:0000269|PubMed:20457600, ECO:0000269|PubMed:24520859,
CC       ECO:0000269|PubMed:24665361}.
CC   -!- INDUCTION: Repressed by glucose and induced by ethanol via the
CC       transcriptional activator CAT8. The promoter sequence located between
CC       -397 and -388 contains an upstream activating sequence (UAS)element
CC       whereas the sequence located between -261 and -242 contains an upstream
CC       repressing sequence (URS) element. {ECO:0000269|PubMed:10540293,
CC       ECO:0000269|PubMed:17428308, ECO:0000269|PubMed:3076186,
CC       ECO:0000269|PubMed:8319292, ECO:0000269|PubMed:9425123}.
CC   -!- PTM: Phosphorylated in response to elevated glucose levels, leading
CC       first to reversible inactivation of the enzyme (short-term
CC       inactivation), and at a later stage to proteolytic degradation of the
CC       protein (long-term inactivation). {ECO:0000269|PubMed:3076186}.
CC   -!- DISRUPTION PHENOTYPE: Impairs growth when acetate or ethanol are the
CC       sole carbon source. Leads to reduced chronological lifespan.
CC       {ECO:0000269|PubMed:11452311, ECO:0000269|PubMed:1551398,
CC       ECO:0000269|PubMed:21246628, ECO:0000269|PubMed:23159490,
CC       ECO:0000269|PubMed:24062879}.
CC   -!- MISCELLANEOUS: Yeast isocitrate lyase is the only eukaryotic member of
CC       this family that is located in the cytoplasm, instead of being targeted
CC       to the peroxisome or the glyoxysome. {ECO:0000269|PubMed:9370278}.
CC   -!- SIMILARITY: Belongs to the isocitrate lyase/PEP mutase superfamily.
CC       Isocitrate lyase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61271; CAA43575.1; -; Genomic_DNA.
DR   EMBL; X65554; CAA46523.1; -; Genomic_DNA.
DR   EMBL; U18813; AAB64601.1; -; Genomic_DNA.
DR   EMBL; BK006939; DAA07724.1; -; Genomic_DNA.
DR   PIR; S22386; WZBYI.
DR   RefSeq; NP_010987.3; NM_001178956.3.
DR   PDB; 7EBC; X-ray; 2.30 A; A/B/C/D=1-557.
DR   PDBsum; 7EBC; -.
DR   AlphaFoldDB; P28240; -.
DR   SMR; P28240; -.
DR   BioGRID; 36807; 82.
DR   DIP; DIP-1663N; -.
DR   IntAct; P28240; 2.
DR   MINT; P28240; -.
DR   STRING; 4932.YER065C; -.
DR   MaxQB; P28240; -.
DR   PaxDb; P28240; -.
DR   PRIDE; P28240; -.
DR   EnsemblFungi; YER065C_mRNA; YER065C; YER065C.
DR   GeneID; 856794; -.
DR   KEGG; sce:YER065C; -.
DR   SGD; S000000867; ICL1.
DR   VEuPathDB; FungiDB:YER065C; -.
DR   eggNOG; KOG1260; Eukaryota.
DR   HOGENOM; CLU_019214_2_2_1; -.
DR   InParanoid; P28240; -.
DR   OMA; LEKDWAE; -.
DR   BioCyc; YEAST:YER065C-MON; -.
DR   SABIO-RK; P28240; -.
DR   UniPathway; UPA00703; UER00719.
DR   PRO; PR:P28240; -.
DR   Proteomes; UP000002311; Chromosome V.
DR   RNAct; P28240; protein.
DR   GO; GO:0005737; C:cytoplasm; IDA:SGD.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-KW.
DR   GO; GO:0005773; C:vacuole; IEA:UniProtKB-SubCell.
DR   GO; GO:0004451; F:isocitrate lyase activity; IMP:SGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046421; F:methylisocitrate lyase activity; IEA:UniProtKB-EC.
DR   GO; GO:0006097; P:glyoxylate cycle; IMP:SGD.
DR   GO; GO:0006099; P:tricarboxylic acid cycle; IEA:UniProtKB-KW.
DR   CDD; cd00377; ICL_PEPM; 1.
DR   Gene3D; 3.20.20.60; -; 1.
DR   InterPro; IPR039556; ICL/PEPM.
DR   InterPro; IPR006254; Isocitrate_lyase.
DR   InterPro; IPR018523; Isocitrate_lyase_ph_CS.
DR   InterPro; IPR015813; Pyrv/PenolPyrv_Kinase-like_dom.
DR   InterPro; IPR040442; Pyrv_Kinase-like_dom_sf.
DR   PANTHER; PTHR21631; PTHR21631; 1.
DR   Pfam; PF00463; ICL; 1.
DR   PIRSF; PIRSF001362; Isocit_lyase; 1.
DR   SUPFAM; SSF51621; SSF51621; 1.
DR   TIGRFAMs; TIGR01346; isocit_lyase; 1.
DR   PROSITE; PS00161; ISOCITRATE_LYASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cytoplasm; Extracellular matrix; Glyoxylate bypass; Lyase;
KW   Magnesium; Metal-binding; Phosphoprotein; Reference proteome; Secreted;
KW   Tricarboxylic acid cycle; Vacuole.
FT   CHAIN           1..557
FT                   /note="Isocitrate lyase"
FT                   /id="PRO_0000068799"
FT   ACT_SITE        217
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305"
FT   BINDING         106..108
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WKK7"
FT   BINDING         179
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P9WKK7"
FT   BINDING         218..219
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WKK7"
FT   BINDING         254
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WKK7"
FT   BINDING         437..441
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WKK7"
FT   BINDING         471
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P9WKK7"
FT   MOD_RES         53
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         53
FT                   /note="T->A: Abolishes short-term enzyme inactivation by
FT                   glucose addition."
FT                   /evidence="ECO:0000269|PubMed:8641464"
FT   MUTAGEN         216
FT                   /note="K->R: Reduces activity by 45%; when associated with
FT                   L-220."
FT                   /evidence="ECO:0000269|PubMed:8923733"
FT   MUTAGEN         220
FT                   /note="M->L: Reduces activity by 45%; when associated with
FT                   R-216."
FT                   /evidence="ECO:0000269|PubMed:8923733"
FT   HELIX           12..30
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           33..35
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           44..48
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           60..78
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          82..86
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           90..96
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   TURN            97..99
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          103..105
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           107..113
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          122..125
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           131..154
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           160..166
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          176..179
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          184..186
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           187..200
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          203..210
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          212..214
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           228..244
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          250..255
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           257..259
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           269..274
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           286..295
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           300..314
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           319..329
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           335..345
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   TURN            348..350
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           354..365
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          372..374
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          383..385
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           389..399
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           400..402
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          404..408
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           415..426
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          433..437
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          440..442
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           444..447
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           450..461
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   TURN            462..464
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   STRAND          465..470
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           473..492
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           494..500
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           502..508
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           511..513
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           515..519
FT                   /evidence="ECO:0007829|PDB:7EBC"
FT   HELIX           521..531
FT                   /evidence="ECO:0007829|PDB:7EBC"
SQ   SEQUENCE   557 AA;  62409 MW;  15CC5A169CCEBE8B CRC64;
     MPIPVGNTKN DFAALQAKLD ADAAEIEKWW SDSRWSKTKR NYSARDIAVR RGTFPPIEYP
     SSVMARKLFK VLEKHHNEGT VSKTFGALDP VQISQMAKYL DTIYISGWQC SSTASTSNEP
     GPDLADYPMD TVPNKVEHLF KAQLFHDRKQ LEARSKAKSQ EELDEMGAPI DYLTPIVADA
     DAGHGGLTAV FKLTKMFIER GAAGIHMEDQ TSTNKKCGHM AGRCVIPVQE HVNRLVTIRM
     CADIMHSDLI VVARTDSEAA TLISSTIDTR DHYFIVGATN PNIEPFAEVL NDAIMSGASG
     QELADIEQKW CRDAGLKLFH EAVIDEIERS ALSNKQELIK KFTSKVGPLT ETSHREAKKL
     AKEILGHEIF FDWELPRVRE GLYRYRGGTQ CSIMRARAFA PYADLVWMES NYPDFQQAKE
     FAEGVKEKFP DQWLAYNLSP SFNWPKAMSV DEQHTFIQRL GDLGYIWQFI TLAGLHTNAL
     AVHNFSRDFA KDGMKAYAQN VQQREMDDGV DVLKHQKWSG AEYIDGLLKL AQGGVSATAA
     MGTGVTEDQF KENGVKK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024